ArticleOPEN ACCESS

Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Cancer Communications
DOI: 10.1002/cac2.12150
6Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Yi, J. H., Kim, S. J., Yoon, D. H., Suh, C., Chang, M. H., Yang, D. H., … Kim, W. S. (2021, March 1). Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis. Cancer Communications. John Wiley and Sons Inc. https://doi.org/10.1002/cac2.12150

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free